Web Results

Johnson & Johnson

en.wikipedia.org/wiki/Johnson_&_Johnson

Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industri...

J&J Wins U.S. Approval for First-in-Class Diabetes Drug - Bloomberg

www.bloomberg.com/news/articles/2013-03-29/jj-wins-u-s-approval-for-first-in-diabetes-drug-class

Mar 29, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry its use in women will be somewhat minimal,” Butler said.

Diabetes Drug Shakeup: What You Need to Know About New FDA ...

www.fool.com/investing/general/2016/04/19/diabetes-drug-shakeup-what-you-need-to-know-about.aspx

Apr 19, 2016 ... (NYSE:LLY) and will almost certainly turn out positive for Johnson & Johnson ( NYSE:JNJ). ... This drug was the latest SGLT2 to win approval in the U.S., but that was ... Maybe it's the diabetes care relationships built through its ...

Invokana Wins F.D.A. Approval for Diabetes Treatment - The New ...

www.nytimes.com/2013/03/30/business/invokana-wins-fda-approval-for-diabetes-treatment.html

Mar 30, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, by causing blood sugar to be ...

FDA Approves Johnson Johnsons New Diabetes Drug

www.biospace.com/News/fda-approves-johnson-johnsons-new-diabetes-drug/291961

Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of ... Janssen will partner with other Johnson & Johnson companies focused on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.

FDA Approves First in New Class of Diabetes Drugs - Invokana

www.drugwatch.com/2013/04/05/new-diabetes-drug-approved-by-fda/

Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ... As the first company to win FDA approval, Johnson & Johnson has a leg up on industry rivals developing their own ... More details on the studies will be presented at the American Diabetes Association annual meeting in June.

SGLT2 Inhibitors, Farxiga, Invokana, Jardiance. Questionable New ...

www.phlaunt.com/diabetes/36474059.php

The FDA recently gave its approval to several new drugs that are part of a new class of ... The first of these was Johnson & Johnson's drug canagliflozin, which is ... As is the case with all new diabetes drugs, now that the drug is approved, drug ... the rest of the side effects of this new class of drugs won't begin to bec...

FDA approves Johnson & Johnson's first-in-class SGLT2 inhibitor ...

www.firstwordpharma.com/node/1068948?tsid=33

Mar 29, 2013 ... The FDA on Friday cleared Johnson & Johnson's Invokana (canaglifozin), ... "I worry its use in women will be somewhat minimal," Butler said. ... Finance); J&J Wins U.S. Approval for First in Diabetes Drug Class - (Bloomberg) ...

U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin ...

www.reuters.com/article/johnsonjohnson-diabetes-idUSL3N0CL1FV20130329

Mar 29, 2013 ... U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin ... from Johnson & Johnson, making it the first in its class to be approved in ... Republicans win Obamacare legal challenge, add to insurer concerns | Video.

Johnson & Johnson, ViaCyte testing possible diabetes cure ...

www.staradvertiser.com/breaking-news/johnson-johnson-viacyte-testing-possible-diabetes-cure/

Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes ... Researchers at universities and other drug companies also are working toward a diabetes cure, ... “We wanted to hedge our bets to make sure we would win in this ... If that goes well, in the next round of testing a few dozen patients will ...

More Info

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the ...

www.fool.com

Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 ... Express Scripts expects spending on diabetes treatment will grow 11% in ... AstraZeneca (NYSE: AZN) won FDA approval for its SGLT2 drug, Farxiga, in January.

UPDATED: J&J wins first FDA approval for new class of diabetes drug

www.fiercebiotech.com

Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ... UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a relatively high rate of genital infections which will limit uptake in our ...

J&J faces big spending, big rivals for new diabetes drug Invokana ...

www.fiercepharma.com

Apr 1, 2013 ... Johnson & Johnson's new diabetes drug Invokana, previously known as canagliflozin, is the first FDA-approved treatment in a new class. ... It offers the promise of a novel approach to diabetes treatment, but because it's new, doctors may ... And J&J ($JNJ) will have to spend a pretty penny on detailing an...